Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Soligenix Inc

(NASDAQ: SNGX)
Add to Portfolio
+0.0100 (+0.68%)
as of Apr 3, 2020

Last 1.4800
Change +0.0100 (+0.68%)
Open 1.4900
Prev. Close 1.4700
Today's Range
1.4500
1.7500
52wk Range
0.6500
3.5400
Volume 1397000
Avg Volume 725295
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
SNGX +0.68% -50.34% +69.72%
DJIA -1.69% -27.80% -19.70%
S&P 500 -1.51% -25.17% -13.39%

Key Statistics

Annual EPS -0.4900
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 35020
Weighted Alpha +50.10
Standard Deviation +0.07
Profit Margin -307.47%
Beta 1.3700

Growth Rates

YTD +2.07%
1-Year +63.46%
3-Year -38.84%
5-Year -90.45%
10-Year -97.36%

Opinion

Sell Hold Buy

Recent Headlines

Soligenix Announces Recent Accomplishments And

PR Newswire via COMTEX - Mon Mar 30, 07:00AM EDT
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its (full story)
SNGXD: 4.1500 (-0.2500), SNGX: 1.4800 (+0.0100)

Soligenix Inc. Heat-Stabilization Platform Evaluating

Newsfile Corp via COMTEX - Tue Mar 24, 09:12AM EDT
New York, New York--(Newsfile Corp. - March 24, 2020) - Soligenix Inc. (NasdaqGS: SNGX), through its Public Health Solutions business segment, on Monday that the company is expanding its ongoing collaboration with the University(full story)
SNGXD: 4.1500 (-0.2500), SNGX: 1.4800 (+0.0100)

Soligenix and University of HawaiÊ"i at Manoa

PR Newswire via COMTEX - Mon Mar 23, 07:00AM EDT
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that(full story)
SNGXD: 4.1500 (-0.2500), SNGX: 1.4800 (+0.0100)

Soligenix, Inc. Impresses With Statistically

Newsfile Corp via COMTEX - Fri Mar 20, 08:38AM EDT
New York, New York--(Newsfile Corp. - March 20, 2020) - Soligenix, on Thursday, announced positive topline data for its lead CTCL drug candidate, SGX301. The published data demonstrated statistically significant efficacy results i(full story)
SNGXD: 4.1500 (-0.2500), SNGX: 1.4800 (+0.0100)

Soligenix Announces Positive Top-line Results for its

PR Newswire via COMTEX - Thu Mar 19, 06:00AM EDT
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today posi(full story)
SNGXD: 4.1500 (-0.2500), SNGX: 1.4800 (+0.0100)